VXRT trade ideas
Today,s beast!It's important to remove your emotions and your ever thinking and smart head out of the Game! Watching Targets is useless.You don't need them!!! You keep the trade that works for you for dear! That winning trade will pay for all your small calculated carefully losses and much, much more!! How to do it? Use the Trailing Stop following your trade at 2 x ART of the last 20 days! You can find that ARE valid at the Barchart.com under the Technical Analysis for your stock!
VXRT repeat breakout patternVXRT showing repeat breakout pattern within a parallel channel. Looking for 5 EMA to cross 20 EMA and MACD cross: if you look at the prior breakout, price moved outside the downtrend and traded sideways until the the 5/20 EMA cross and MACD crossing up. MACD is currently reading -.005, so I expect the next positive trading day to result in the MACD crossing up and the 5/20 EMA cross which I expect to be the catalyst for another move higher.
I am looking to buy this one right here against the 50 EMA and the rising 5 day EMA.
Swallow your Flu shotYesterday positive results from phase 2 study of their oral vaccine against flu was released.
Seeking alpha: The vaccine elicited a significant expansion of mucosal homing receptor alfa4beta7+ (beta7+) plasmablasts, cells that play a key role in an immune response, to about 60% of all activated B cells, significantly higher than 20% from Sanofi's (NYSE:SNY) Fluzone.
FYI , SNY is 100B company.
Something to watch. Another high risk potentially high reward. If this falls below the 20 ema tomorrow. I’d expect to see some resistance between 2.40 and 2.00
This may bounce off the 20 ema tomorrow. We shall see. Honestly since this is in the bio sector I’m pretty skittish on this one. I picked mitt last week as a financial swing and that worked out nicely. Check my analysis on it. That run may not be over yet, but I’m out of it for now.
The price predictions are based upon the respect for the weekly 20ema and the fibs and pivots.
Just something I’m watching at the moment. I may buy in.
Just a reminder. I’m not a pro and my style is based upon Shorter term swing trading. 1-5 day holds
VXRT - Big Moves AheadAll,
This may drop to $2.30-2.50 but after that should be a move up. We are moving into a previous consolidation area. The news etc outlook prior to the virus all look like it should move up. However, you never know so keep an eye out of course. We should see some movement this week for sure.
VXRT Short - Bad bet on CoronaAside from the short term stimulus in the headlines, there is really no upside in product pipeline.
The stock itself looks to be developing a HS pattern. Will probably be heading down in the short term. Consolidate in the mid term. Heading lower in the long term.
This is assuming it has no major development in its products. Recipe for investment destruction.
$VXRT on alert for breakoutBiotech Vaxart (VXRT) has announced positive pre-clinical results for its oral COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose.
Shares have surged 35% in pre-market trading Tuesday, with the stock’s year-to-date gain already at an eye-watering 567%.
“These early pre-clinical results are in line with those for our oral influenza vaccine which was protective in a clinical Phase 2 efficacy study,” said Sean Tucker, Ph.D., CSO of Vaxart, adding that additional data will inform which candidate moves forward into clinical trials. Source smarteranalysis
$VXRT bullish on Data Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose.
“These early pre-clinical results are in line with those for our oral influenza vaccine which was protective in a clinical Phase 2 efficacy study,” said Sean Tucker, Ph.D., chief scientific officer of Vaxart. “Additional data will inform us on which candidate we will move forward into clinical trials. We are particularly interested in vaccine candidates that can generate mucosal immune responses in addition to serum antibody responses. That is a key feature of our oral vaccines and potentially significant for protection against SARS CoV-2, the virus that causes COVID-19.”
Source Globalnewswire
VAXART INC Approaching resistance | Price TargetsVaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.
VAXART - Coronavirus stockVaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.
Vaxart, Inc. Trend-line break possible Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.
VXRT Very Strong RunVXRT stock had a great run today due to positive news from their norovirus vaccine. Shs Float is at 3.96M and their market cap is 16.12M. We will be watching this for a continuation play tomorrow. Watch my full video review for $VXRT by using the link in my signature description!
